ZoetisMEX:ZTS -2.46%71 PB Ratio is 9.65 as of Jun. 27, 2026, which is 47% below its 10-year median of 18.18. GuruFocus rates MEX:ZTS with a GF Score™ of 71/100 and a GF Value™ of MXN3,418.50 (Significantly Undervalued). Among 922 Drug Manufacturers companies, Zoetis ranks worse than 92.73% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Zoetis's share price is MXN1338.00. Zoetis's Book Value per Share for the quarter that ended in Mar. 2026 was MXN138.69. Hence, Zoetis's PB Ratio of today is 9.65.
Good Sign:
Zoetis Inc stock PB Ratio (=10.12) is close to 10-year low of 9.65.
The historical rank and industry rank for Zoetis's PB Ratio or its related term are showing as below:
MEX:ZTS'
s PB Ratio Range Over the Past 10 Years
Min: 9.65 Med: 18.18 Max: 25.62
Current: 9.87
During the past 13 years, Zoetis's highest PB Ratio was 25.62. The lowest was 9.65. And the median was 18.18.
MEX:ZTS's PB Ratio is ranked worse than 92.73% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs MEX:ZTS: 9.87
During the past 12 months, Zoetis's average Book Value Per Share Growth Rate was -26.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 16.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Zoetis was 29.60% per year. The lowest was -35.60% per year. And the median was 11.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Zoetis PB Ratio Related Terms
Zoetis PB Ratio Historical Data
* Premium members only.
The historical data trend for Zoetis's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zoetis PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zoetis's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zoetis's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Zoetis's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Zoetis (MEX:ZTS) has a PB Ratio of 9.65 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zoetis and its competitors. This is 47% below median its historical median of 18.18. Over the past decade, Zoetis' PB Ratio has ranged from 9.65 to 25.62. According to the industry distribution chart, Zoetis ranks #855 out of 922 companies in the Drug Manufacturers industry, placing it in the top 92.7%.
Is Zoetis' PB Ratio too high?
Zoetis' current PB Ratio of 9.65 is 47% below median its 10-year median of 18.18. Over the past 10 years, this metric has ranged from a low of 9.65 to a high of 25.62. The Drug Manufacturers industry median PB Ratio is 1.83. Zoetis' value of 9.65 is 428.8% above this industry median. Based on the distribution chart, Zoetis ranks #855 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zoetis has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' PB Ratio compare to UTHR and VTRS?
According to the Drug Manufacturers industry distribution chart, Zoetis ranks #855 out of 922 companies for PB Ratio. This places Zoetis in the lower half of its industry. The industry median PB Ratio is 1.83. Zoetis' value of 9.65 is 428.8% above this benchmark. Historically, Zoetis' own PB Ratio has ranged from 9.65 to 25.62 over the past decade. While the company's 10-year median is 18.18 vs. the industry median of 1.83, Zoetis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zoetis's current PB Ratio of 9.65 is 428.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zoetis and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zoetis's current PB Ratio is 9.65, which is 47% below median its own 10-year median of 18.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (MEX:ZTS) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN3,418.50, compared to a current price of MXN1,338.00 — trading 60.9% below its estimated fair value. The current PB Ratio is 9.65, which is 47% below median its 10-year median of 18.18 and 428.8% above the Drug Manufacturers industry median of 1.83. Zoetis' overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Zoetis (MEX:ZTS), the current PB Ratio is 9.65 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zoetis (MEX:ZTS) Overvalued in 2026?
Based on GuruFocus' analysis, Zoetis stock appears to be undervalued.
The current stock price of MXN1,338.00 is trading 60.9% below its estimated GF Value™ of MXN3,418.50.
GuruFocus considers Zoetis to be Significantly Undervalued.
Key valuation signals for MEX:ZTS:
PB Ratio: 9.65 (47% below median its 10-year median of 18.18)
GF Value™: MXN3,418.50 vs. price of MXN1,338.00 (60.9% below fair value)
Industry Position: 428.8% above the Drug Manufacturers median (#855 of 922)
No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
71GF Score
Get the complete analysis for MEX:ZTS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ZTS has been successfully added to your 
